Want to see DCGO full AI Analyst Report?
DCGO Stock Chart & Stats
$0.65
-$0.06(-1.42%)
At close: 4:00 PM EST
$0.65
-$0.06(-1.42%)
Day’s Range― - ―
52-Week Range$0.45 - $1.78
Previous CloseN/A
Volume125.49K
Average Volume (3M)1.04M
Market Cap
$64.32M
Enterprise Value$33.85
Total Cash (Recent Filing)$35.68M
Total Debt (Recent Filing)$28.51M
Price to Earnings (P/E)―
Beta1.43
Next Earnings
Aug 10, 2026EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.91
Shares Outstanding98,778,410
10 Day Avg. Volume640,703
30 Day Avg. Volume1,039,525
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.60
Price to Sales (P/S)0.27
P/FCF Ratio3.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$2.38Price Target Upside265.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.33
Revenue Forecast (FY)$298.67M
Bulls Say, Bears Say
Bulls Say
Business Model: B2B/B2G Mobile & Transport CareDocGo's service‑based B2B/B2G model relies on multi‑month/ multi‑year contracts to deploy clinicians, transport and virtual capabilities. That contract orientation creates recurring service fees, stickiness with health systems and payers, and a structural role in shifting care to lower‑cost settings.
Volume Momentum And Raised Revenue GuidanceManagement raised full‑year revenue guidance and reported record quarterly volumes across transportation, home health and virtual care. Sustained volume growth and renewals (including transport renewals and new contracts) support durable top‑line scaling and the potential for future operating leverage as unit economics improve.
Manageable Leverage / Balance Sheet FlexibilityLow reported leverage gives DocGo flexibility to fund growth initiatives, extend a share repurchase program, or absorb short‑term cash variability without heavy reliance on new debt. This balance‑sheet headroom supports strategic investments in expansion and technology while navigating operational headwinds.
Bears Say
Severe Cash‑flow Deterioration (TTM 2026)Operating and free cash flow swung to a large negative in the trailing twelve months, reversing earlier positive cash generation. Persistent cash burn threatens liquidity, limits reinvestment, and increases dependence on external financing or asset sales to fund operations if negative cash flow continues.
Profitability Flipped To Large LossesAfter modest profitability through 2024, operating performance deteriorated meaningfully and margins turned deeply negative. Even with a stable ~30% gross margin, sharply higher operating costs and incentives eroded EBITDA, weakening the firm's ability to self‑fund growth and raising uncertainty about sustainable profitability.
Revenue Volatility, Non‑recurring Mix & Receivables RiskRecent revenue was affected by one‑off migrant programs that have wound down and by acquisitions (SteadyMD) requiring transitional incentives. Outstanding receivables and timing issues increase working‑capital volatility, making near‑term revenue and cash flows more sensitive to contract timing and collection execution.
DocGo News
DCGO FAQ
What was DocGo, Inc.’s price range in the past 12 months?
DocGo, Inc. lowest stock price was $0.45 and its highest was $1.78 in the past 12 months.
What is DocGo, Inc.’s market cap?
DocGo, Inc.’s market cap is $64.32M.
When is DocGo, Inc.’s upcoming earnings report date?
DocGo, Inc.’s upcoming earnings report date is Aug 10, 2026 which is in 20 days.
How were DocGo, Inc.’s earnings last quarter?
DocGo, Inc. released its earnings results on May 11, 2026. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.122 by -$0.028.
Is DocGo, Inc. overvalued?
According to Wall Street analysts DocGo, Inc.’s price is currently Undervalued.
Does DocGo, Inc. pay dividends?
DocGo, Inc. does not currently pay dividends.
What is DocGo, Inc.’s EPS estimate?
DocGo, Inc.’s EPS estimate is -0.1.
How many shares outstanding does DocGo, Inc. have?
DocGo, Inc. has 98,778,410 shares outstanding.
What happened to DocGo, Inc.’s price movement after its last earnings report?
DocGo, Inc. reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.122. Following the earnings report the stock price went up 0.507%.
Which hedge fund is a major shareholder of DocGo, Inc.?
Currently, no hedge funds are holding shares in DCGO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DocGo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.38 (265.38% Upside)
$2.38 (265.38% Upside)
Blogger Sentiment
Bullish
DCGO Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 125.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.14%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-51.43%
Trailing 12-Months
Company Description
DocGo, Inc.
DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom. Their transportation portfolio includes critical emergency response, alongside routine non-emergency transfers facilitated by ambulance and specialized wheelchair-accessible vehicles. Additionally, DocGo offers a range of mobile health services, delivered directly to patients' homes and offices through its advanced digital platform. These services further extend to include COVID-19 diagnostic testing and comprehensive on-site healthcare support for various events, such as large sporting competitions and concerts. The company was founded in 2015 and is headquartered in New York, New York.
DCGO Stock 12 Month Forecast
Average Price Target
$2.38
▲(265.38% Upside)
Technical Analysis
Ownership Overview
6.99% Insiders
8.26% Mutual Funds
1.56% Other Institutional Investors
78.55% Public Companies and
Individual Investors